Lv42
570 积分 2026-01-07 加入
Immune checkpoint inhibitors associated thyroiditis: mechanisms and clinical outcomes
12天前
已完结
NICHE-2 validates the efficacy of neoadjuvant ICIs in dMMR colon cancer
25天前
已完结
The current status of immunotherapy in colorectal cancer: A systematic review
25天前
已完结
Pembrolizumab in Microsatellite-Instability–High Advanced Colorectal Cancer
26天前
已完结
Atezolizumab plus FOLFOX for Stage III Mismatch Repair–Deficient Colon Cancer
26天前
已完结
Adjuvant immunotherapy does not improve survival in non–small cell lung cancer with major/complete pathologic response after induction immunotherapy
1个月前
已完结
Perioperative Toripalimab Plus Chemotherapy for Patients With Resectable Non–Small Cell Lung Cancer
1个月前
已完结
Abstract CT014: Perioperative adebrelimab (A) plus chemotherapy (chemo) in resectable stage II-III NSCLC: Phase 3 EFS interim analysis (IA) and molecular residual disease (MRD) analysis
1个月前
已关闭
Perioperative Toripalimab Plus Chemotherapy for Patients With Resectable Non–Small Cell Lung Cancer
2个月前
已完结
Overall Survival with Neoadjuvant Nivolumab plus Chemotherapy in Lung Cancer
2个月前
已完结
皖公网安备34019202002308
